
Tyme Investor Relations Material
Latest events

Q3 2022
Tyme
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tyme Technologies Inc
Access all reports
Tyme Technologies Inc was a biotechnology company that developed cancer metabolism-based therapies aimed at targeting and disrupting cancer cell metabolism. The company focused on developing novel therapeutic candidates for the treatment of various types of cancer. Tyme Technologies served the oncology sector through research-driven initiatives. The company was headquartered in Bedminster, New Jersey, and its shares were listed on the NASDAQ.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
TYME
Country
🇺🇸 United States